Earnings History Data for Mirum Pharmaceuticals (MIRM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Mirum Pharmaceuticals

Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's product candidate consists of maralixibat, an investigational oral drug in development for progressive familial intrahepatic cholestasis and Alagille syndrome. Mirum Pharmaceuticals Inc. is based in Foster City, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-02-2024	AH		MIRM	Mirum Pharmaceuticals	1,296	-0.66	-0.33	0.00	Mirum Pharmaceuticals reports Q4 results [2/28/2024 4:16 PM]	28.79	-0.10 (-0.35%)	29.49	0.60 (2.08%)	20.81 - 35.56	758,738	340,000	479
Mirum Pharmaceuticals reports Q4 results [2/28/2024 4:16 PM]
02-11-2023	AH		MIRM	Mirum Pharmaceuticals, Inc.	1,050	-0.57	-0.64	-1.02	Mirum Pharmaceuticals GAAP EPS of -$0.57, revenue of $47.7M [11/2/2023 4:51 PM]	30.00	1.61 (5.67%)	28.99	0.60 (2.11%)	17.49 - 33.39	1,418,863	340,000	415
Mirum Pharmaceuticals GAAP EPS of -$0.57, revenue of $47.7M [11/2/2023 4:51 PM]
03-08-2023	AH		MIRM	Mirum Pharmaceuticals, Inc.	949.65	-0.92	-0.81	-0.84	Mirum Pharmaceuticals GAAP EPS of -$1.94 misses by $1.14, revenue of $37.5M beats by $7.06M [8/3/2023 4:41 PM]	26.49	1.61 (6.47%)	24.88	0.0 (0.00%)	17.32 - 30.55	827,123	580,000	44,814
Mirum Pharmaceuticals GAAP EPS of -$1.94 misses by $1.14, revenue of $37.5M beats by $7.06M [8/3/2023 4:41 PM]
04-05-2023	AH	After the close (May 4)	MIRM	Mirum Pharmaceuticals, Inc.	1,030	-0.80	-0.96	-1.17	Mirum Pharmaceuticals Non-GAAP EPS of -$0.80 beats by $0.17, revenue of $31.6M beats by $0.81M [5/4/2023 5:33 PM]	26.19	-1.66 (-5.96%)	28.79	0.94 (3.38%)	17.32 - 30.55	462,097	480,000	201
Mirum Pharmaceuticals Non-GAAP EPS of -$0.80 beats by $0.17, revenue of $31.6M beats by $0.81M [5/4/2023 5:33 PM]
08-03-2023	AH	After the close (Mar 8)	MIRM	Mirum Pharmaceuticals, Inc.	866.82	-0.99	-0.98	-0.92	Mirum Pharmaceuticals reports Q4 results [3/8/2023 4:58 PM]	23.62	-0.14 (-0.59%)	23.75	-0.01 (-0.04%)	17.32 - 30.55	341,416	190,000	15,594
Mirum Pharmaceuticals reports Q4 results [3/8/2023 4:58 PM]
09-11-2022	PM	8:00 AM ET (Nov 9)	MIRM	Mirum Pharmaceuticals, Inc.	870.65	-1.02	-1.05	-1.55	Mirum Pharmaceuticals GAAP EPS of -$1.02 beats by $0.05, revenue of $18.78M misses by $2.03M [11/9/2022 7:38 AM]	20.03	-3.91 (-16.33%)	22.22	-1.72 (-7.18%)	12.82 - 30.55	855,645	270,000	1,106
Mirum Pharmaceuticals GAAP EPS of -$1.02 beats by $0.05, revenue of $18.78M misses by $2.03M [11/9/2022 7:38 AM]
04-08-2022	AH	4:00 PM ET (Aug 4)	MIRM	Mirum Pharmaceuticals, Inc.	779.04	-0.84	-1.05	-1.45	Mirum Pharmaceuticals GAAP EPS of -$0.84 beats by $0.31, revenue of $17.5M beats by $2.08M [8/4/2022 4:04 PM]	29.44	3.39 (13.01%)	26.02	-0.03 (-0.12%)	12.82 - 30.00	789,745	190,000	402
Mirum Pharmaceuticals GAAP EPS of -$0.84 beats by $0.31, revenue of $17.5M beats by $2.08M [8/4/2022 4:04 PM] Mirum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-04-22 04:01PM] Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates [Aug-04-22 05:55PM]
05-05-2022	PM	4:00 PM ET (May 5)	MIRM	Mirum Pharmaceuticals, Inc.	775.04	-1.17	-1.39	-1.68	Mirum Pharmaceuticals GAAP EPS of -$1.17 beats by $0.23, revenue of $12.89M beats by $4.43M [5/5/2022 9:09 AM]	25.19	1.61 (6.83%)	23.58	0.0 (0.00%)	12.82 - 28.65	176,671	120,000	1,206
Mirum Pharmaceuticals GAAP EPS of -$1.17 beats by $0.23, revenue of $12.89M beats by $4.43M [5/5/2022 9:09 AM] Mirum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update [May-05-22 08:00AM] Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Tops Revenue Estimates [May-05-22 09:25AM]
09-03-2022	AH	4:00 PM ET (Mar 9)	MIRM	Mirum Pharmaceuticals, Inc.	653.82	-0.92	0.03	-1.43	Mirum Pharmaceuticals reports Q4 results [3/9/2022 4:04 PM]	22.75	-0.05 (-0.22%)	22.80	0.0 (0.00%)	0.0 - 0.0	243,411	0	1,354
Mirum Pharmaceuticals reports Q4 results [3/9/2022 4:04 PM] Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update [Mar-09-22 04:00PM]
15-11-2021	AH	4:00 PM ET (Nov 15)	MIRM	Mirum Pharmaceuticals, Inc.	487.03	-1.55	-1.63	-0.86	Mirum Pharmaceuticals reports Q3 results [11/15/2021 4:14 PM]	15.85	0.36 (2.32%)	15.49	0.0 (0.00%)	13.85 - 26.31	229,872	120,000	255
Mirum Pharmaceuticals reports Q3 results [11/15/2021 4:14 PM] Six-Year Natural History Comparison with Mirums LIVMARLI (maralixibat) Demonstrates Event-Free Survival and Transplant-Free Survival in Patients with Alagille Syndrome [Nov-15-21 12:30PM] Mirum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-15-21 04:01PM] Mirum Pharmaceuticals, Inc. (MIRM) Reports Q3 Loss [Nov-15-21 05:25PM]
05-08-2021	AH	4:05 PM ET (Aug 5)	MIRM	Mirum Pharmaceuticals, Inc.	440.05	-1.45	-0.41	-0.93	Mirum Pharmaceuticals beats on revenue [8/5/2021 4:55 PM]	14.67	0.13 (0.89%)	14.63	0.0 (0.00%)	13.85 - 27.43	300,243	80,000	481
Mirum Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-05-21 04:02PM] Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Misses Revenue Estimates [Aug-05-21 06:35PM]
06-05-2021	AH	4:00 PM ET (May 6)	MIRM	Mirum Pharmaceuticals, Inc.	598.26	-1.68	-0.67	-0.86	Mirum Pharmaceuticals reports Q1 results [5/6/2021 4:24 PM]	18.67	0.97 (5.48%)	18.67	0.0 (0.00%)	14.94 - 27.43	52,227	60,000	213
Mirum Pharmaceuticals reports Q1 results [5/6/2021 4:24 PM] Mirum Pharmaceuticals Inc to Host Earnings Call [May-06-21 02:30PM] Mirum Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update [May-06-21 04:05PM] Mirum Pharmaceuticals, Inc. (MIRM) Reports Q1 Loss, Lags Revenue Estimates [May-06-21 07:50PM]
09-03-2021	AH	After the close (Mar 9)	MIRM	Mirum Pharmaceuticals, Inc.	449.00	-1.43	-0.57	0.00	Mirum Pharmaceuticals EPS misses by $0.49 [3/9/2021 4:40 PM]	18.48	-0.02 (-0.11%)	18.50	0.0 (0.00%)	9.14 - 27.43	164,445	164,512	453
Mirum Pharmaceuticals EPS misses by $0.49 [3/9/2021 4:40 PM] Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Results and Provides Business Updates [Mar-09-21 04:02PM] Why Earnings Season Could Be Great for Mirum Pharmaceuticals (MIRM) [Mar-09-21 09:09AM] Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Lags Revenue Estimates [Mar-09-21 05:25PM] Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Mar-10-21 06:00PM]
12-11-2020	PM		MIRM	Mirum Pharmaceuticals, Inc.	465.57	-0.86	-0.99	-0.84	Mirum Pharmaceuticals EPS beats by $0.32 [11/12/2020 9:08 AM]	17.20	-0.76 (-4.23%)	17.20	0.0 (0.00%)	6.51 - 28.31	50,976	55,880	1,223